Literature DB >> 15358121

Bax-inhibiting peptide derived from mouse and rat Ku70.

Tomoyuki Yoshida1, Ikuo Tomioka, Takako Nagahara, Trudy Holyst, Motoshi Sawada, Paulette Hayes, Vivian Gama, Misako Okuno, Yuhong Chen, Yasuyuki Abe, Tadashi Kanouchi, Hiroshi Sasada, Demin Wang, Takanori Yokota, Eimei Sato, Shigemi Matsuyama.   

Abstract

Bax is a proapoptotic protein that plays a key role in the induction of apoptosis. Ku70 has activities to repair DNA damage in the nucleus and to suppress apoptosis by inhibiting Bax in the cytosol. We previously designed peptides based on the amino acid sequence of Bax-binding domain of human Ku70, and showed that these peptides bind Bax and inhibit cell death in human cell lines. In the present report, we examined the biological activities of other pentapeptides, VPTLK and VPALR, derived from mouse and rat Ku70. Cells in culture accumulated FITC-labeled VPTLK and VPALR, indicating that these peptides are cell permeable (human, mouse, rat, and porcine cells were examined). These peptides bound to Bax and suppressed cell death in various cell types including primary cultured cells. These data suggest that such Bax inhibiting peptides from three mammalian species may be used to protect healthy cells from apoptotic injury under pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358121     DOI: 10.1016/j.bbrc.2004.07.054

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  30 in total

1.  The DNA-PK catalytic subunit regulates Bax-mediated excitotoxic cell death by Ku70 phosphorylation.

Authors:  Jia Liu; Janice R Naegele; Stanley L Lin
Journal:  Brain Res       Date:  2009-08-04       Impact factor: 3.252

2.  A MedChem toolbox for cereblon-directed PROTACs.

Authors:  Christian Steinebach; Izidor Sosič; Stefanie Lindner; Aleša Bricelj; Franziska Kohl; Yuen Lam Dora Ng; Marius Monschke; Karl G Wagner; Jan Krönke; Michael Gütschow
Journal:  Medchemcomm       Date:  2019-05-28       Impact factor: 3.597

Review 3.  Pharmacological inhibition of Bax-induced cell death: Bax-inhibiting peptides and small compounds inhibiting Bax.

Authors:  Kelsey Jensen; David Jasen WuWong; Sean Wong; Mieko Matsuyama; Shigemi Matsuyama
Journal:  Exp Biol Med (Maywood)       Date:  2019-03-05

4.  Cell-penetrating penta-peptides and Bax-inhibiting peptides: protocol for their application.

Authors:  Jose Gomez; Shigemi Matsuyama
Journal:  Methods Mol Biol       Date:  2011

5.  The BRG1- and hBRM-associated factor BAF57 induces apoptosis by stimulating expression of the cylindromatosis tumor suppressor gene.

Authors:  Li Wang; Robert A Baiocchi; Sharmistha Pal; George Mosialos; Michael Caligiuri; Saïd Sif
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

Review 6.  Bax-induced apoptosis shortens the life span of DNA repair defect Ku70-knockout mice by inducing emphysema.

Authors:  Shigemi Matsuyama; James Palmer; Adam Bates; Izmarie Poventud-Fuentes; Kelvin Wong; Justine Ngo; Mieko Matsuyama
Journal:  Exp Biol Med (Maywood)       Date:  2016-06

7.  Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.

Authors:  Ariel E Feldstein; Nathan W Werneburg; Zhengzheng Li; Steven F Bronk; Gregory J Gores
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-02-16       Impact factor: 4.052

8.  Hdm2 is a ubiquitin ligase of Ku70-Akt promotes cell survival by inhibiting Hdm2-dependent Ku70 destabilization.

Authors:  V Gama; J A Gomez; L D Mayo; M W Jackson; D Danielpour; K Song; A L Haas; M J Laughlin; S Matsuyama
Journal:  Cell Death Differ       Date:  2009-02-27       Impact factor: 15.828

9.  Proinflammatory cytokines activate the intrinsic apoptotic pathway in beta-cells.

Authors:  Lars G Grunnet; Reid Aikin; Morten F Tonnesen; Steven Paraskevas; Lykke Blaabjerg; Joachim Størling; Lawrence Rosenberg; Nils Billestrup; Dusica Maysinger; Thomas Mandrup-Poulsen
Journal:  Diabetes       Date:  2009-05-26       Impact factor: 9.461

10.  Recent developments in peptide-based nucleic acid delivery.

Authors:  Sandra Veldhoen; Sandra D Laufer; Tobias Restle
Journal:  Int J Mol Sci       Date:  2008-07-16       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.